The modulation of nAChRs, particularly α7nAChR, has been demonstrated to treat nervous-system disorders, including schizophrenia as well as depression, and neurodegenerative diseases including AD and Parkinson’s disease (Taly et al., 2009; Hoskin et al., 2019). The gene discussed is CHRNA7; the disease is depressive symptom measurement.